1. Autoantibodies' titre modulation by anti-BlyS treatment in systemic lupus erythematosus. (August 2019) Authors: Cavazzana, I; Kumar, R; Pozzari, C; Ottaviani, R; Fredi, M; Piantoni, S; Andreoli, L; Tincani, A; Franceschini, F Journal: Lupus Issue: Volume 28:Number 9(2019) Page Start: 1074 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0268 Prevalence and features of celiac disease in patients with systemic autoimmune diseases: results of a large multicenter study. (15th June 2017) Authors: Bartoloni, E; Alunno, A; Bistoni, O; Cavagna, L; Nalotto, L; Baldini, C; Priori, R; Picarelli, G; Fischetti, C; Franceschini, F; Quartuccio, L; Carubbi, F; Fredi, M; Montecucco, C; Doria, A; Mosca, M; Valesini, G; Gabrielli, A; Vita, S De; Giacomelli, R Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P007 Autoantibodies' titre changes during anti-BLyS treatment in systemic lupus erythematosus. (March 2019) Authors: Cavazzana, I; Pozzari, C; Kumar, R; Ottaviani, R; Fredi, M; Piantoni, S; Tincani, A; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. THU0251 Familial clustering of autoimmune diseases in sjÖgren's syndrome: an italian case-control study. (1st June 2001) Authors: Priori, R; Conti, F; Cassarà, E; Medda, E; Stazi, MA; Tomassini, C; Bozzolo, E; Franceschini, F; Urbano, T; Giacomelli, R; Valesini, G Journal: Annals of the rheumatic diseases Issue: Volume 60(2001)Supplement 1 Page Start: A312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-MIT3 antibodies in systemic sclerosis. (22nd February 2011) Authors: Cavazzana, I; Taraborelli, M; Ceribelli, A; Fredi, M; Norman, G; Satoh, M; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 70(2011)Supplement 2 Page Start: A84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0448 Use of denosumab in patients with systemic lupus erythematosus: a real life multi-centric experience. (15th June 2017) Authors: Crisafulli, F; Fredi, M; Bortoluzzi, A; Cavazzana, I; Furini, F; Govoni, M; Tincani, A; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0261 Skin cancer in a cohort of systemic lupus erythematosus. (15th June 2017) Authors: Taraborelli, M; Genitori, C; Cavazzana, I; Fredi, M; Tincani, A; Pinton, P Calzavara; Franceschini, F Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. S7A:6 Baseline serum levels of baff or april are independent predictors of sledai response after 12 months of treatment with belimumab in patients with refractory systemic lupus erythematosus. (21st March 2018) Authors: Piantoni, S; Andreoli, L; Lowin, T; Kumar, R; Regola, F; Airò, P; Franceschini, F; Tincani, A; Pongratz, G Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PS1:3 Analysis of c9orf72 expansions in patients with systemic lupus erythematosus and rheumatoid arthritis: preliminary data. (21st March 2018) Authors: Fredi, M; Biasiotto, G; Cavazzana, I; Filosto, M; Padovani, A; Franceschini, F; Zanella, I Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PS5:95 Circulating angiogenic t-cells are reduced in patients with systemic lupus erythematosus with high disease activity and without known cardiovascular risk factors. (21st March 2018) Authors: Piantoni, S; Cavazzana, I; Fredi, M; Taraborelli, M; Franceschini, F; Tincani, A; Airo', P Journal: Lupus science & medicine Issue: Volume 5(2018)Supplement 1 Page Start: A84 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗